Mylan同意在九年内支付3.35亿美元,以解决误导性类阿片销售的索赔。 Mylan agrees to pay $335 million over nine years to settle claims of misleading opioid marketing.

现为Viatris公司一部分的制药公司Mylan Inc.同意在9年内支付3.35亿美元,以解决有关其类阿片产品被误导销售的指控,这些类阿片产品被错误地宣传为不易滥用。 Pharmaceutical company Mylan Inc., now part of Viatris, has agreed to pay $335 million over nine years to settle allegations of misleading marketing of its opioid products, which were falsely promoted as less prone to abuse. 这一涉及多个国家的解决方案旨在为吸毒成瘾治疗和预防服务提供资金。 The settlement, involving multiple states, aims to fund addiction treatment and prevention services. 俄勒冈州和弗吉尼亚州等州预计将收到数百万美元来对付类阿片危机。 States like Oregon and Virginia expect to receive millions to combat the opioid crisis.